Fund Holdings — M28 Capital Management LP

Total Portfolio Value
$53.80M
Total Bought
$0
Total Sold
$69.72M
Net Transaction
-$69.72M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
CURIS INC(CRIS)521,059284,889-236,1705141560.29%-358
SILENCE THERAPEUTICS PLC(SLN)185,100101,203-83,8971,1255330.99%-592
ROCKET PHARMACEUTICALS INC(RCKT)385,680210,871-174,8091,3547551.40%-599
PROQR THRAPEUTICS N V
SHS EURO
1,019,498599,793-419,7052,0599721.81%-1,088
TG THERAPEUTICS INC(TGTX)161,60088,354-73,2464,8172,9355.46%-1,882
ARROWHEAD PHARMACEUTICALS IN(ARWR)67,40036,851-30,5494,4752,3114.29%-2,164
FRACTYL HEALTH INC(GUTS)1,856,1171,856,11704,0838501.58%-3,234
INVIVYD INC(IVVD)9,248,2509,248,250022,84312,02322.35%-10,820
WAVE LIFE SCIENCES LTD(WVE)5,664,5484,588,284-1,076,26496,29733,26561.83%-63,032
Page 1 of 1
M28 Capital Management LP — 13F Holdings — Q1 2026 | TickerTrail